What Does a Private Vaccine Market Mean for Moderna?
Moderna (NASDAQ: MRNA) has brought in billions of dollars in revenue and profit from its coronavirus vaccine. And that's thanks to orders from governments. Last year, Moderna generated $18.5 billion in vaccine revenue. It's heading for $21 billion in product revenue this year, according to advance purchase agreements signed so far.
But Moderna's vaccine story may change. And it could happen as soon as this fall -- at least in the United States. I'm talking about the switch from selling to governments to selling directly to healthcare providers. That's known as the private market. Congress hasn't approved funding to cover purchases of updated coronavirus vaccines for all Americans. And Moderna says it's preparing for a private market in case U.S. funding and orders don't come through. What does this mean for revenue? Let's take a closer look.
Image source: Getty Images.
Source Fool.com
